These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2516866)

  • 1. Intraocular penetration of CT-112, an aldose reductase inhibitor, following topical instillation.
    Ohashi Y; Awata T; Sogo S; Ohira M; Matsuda M; Fukuda M; Manabe R
    J Ocul Pharmacol; 1989; 5(4):325-8. PubMed ID: 2516866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an aldose reductase inhibitor, CT-112, on healing of the corneal epithelium in galactose-fed rats.
    Awata T; Sogo S; Yamagami Y; Yamamoto Y
    J Ocul Pharmacol; 1988; 4(3):195-201. PubMed ID: 3143793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aldose reductase inhibitor, CT-112, on sugar alcohol accumulation in corneal epithelium of galactose-fed rats.
    Awata T; Sogo S; Yamamoto Y
    Jpn J Ophthalmol; 1986; 30(3):245-50. PubMed ID: 3097363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
    Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corneal permeability of aldose reductase inhibitor, M79175. II. In vivo study on pharmacokinetic aspect.
    Kato A; Horie T; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):287-94. PubMed ID: 3139809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients.
    Ohguro N; Matsuda M; Ohashi Y; Fukuda M
    Br J Ophthalmol; 1995 Dec; 79(12):1074-7. PubMed ID: 8562538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The intraocular penetration of ARI (M-79175) in rabbit eyes].
    Kojima M; Sasaki K; Taniguchi T
    Nippon Ganka Gakkai Zasshi; 1987 Jun; 91(6):643-6. PubMed ID: 3120520
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of the aldose reductase inhibitor imirestat following topical ocular administration.
    Brazzell RK; Wooldridge CB; Hackett RB; McCue BA
    Pharm Res; 1990 Feb; 7(2):192-8. PubMed ID: 2106677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro study of aldose reductase inhibitor concentrations in the lens and inhibitory effect on sugar alcohol accumulation.
    Yamamoto Y; Ohtori A
    Curr Eye Res; 1990 May; 9(5):421-8. PubMed ID: 2116955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical aldose reductase inhibitor CT-112 on corneal sensitivity of diabetic rats.
    Hosotani H; Ohashi Y; Kinoshita S; Matsumoto T; Awata T
    Curr Eye Res; 1996 Oct; 15(10):1005-7. PubMed ID: 8921238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal permeability of aldose reductase inhibitor, M79175. I. In vitro study using corneal permeability apparatus.
    Kato A; Ishibashi Y; Miyake Y; Iwata S
    J Ocul Pharmacol; 1986; 2(3):279-86. PubMed ID: 3139808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration.
    Song JS; Kim JH; Yang M; Sul D; Kim HM
    Cornea; 2006 Dec; 25(10 Suppl 1):S20-3. PubMed ID: 17001187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative intraocular penetration of 4 fluoroquinolones after topical instillation.
    Chung JL; Lim EH; Song SW; Kim BY; Lee JH; Mah FS; Seo KY
    Cornea; 2013 Jul; 32(7):1046-51. PubMed ID: 23615274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
    Crabbe MJ; Petchey M; Burgess SE; Cheng H
    Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.
    Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R
    Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
    Hosotani H; Ohashi Y; Yamada M; Tsubota K
    Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of aldose reductase inhibitor on the corneal epithelium.
    Tsubota K; Yamada M
    Cornea; 1993 Mar; 12(2):161-2. PubMed ID: 8500324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular penetration of ketoconazole in rabbits.
    Hemady RK; Chu W; Foster CS
    Cornea; 1992 Jul; 11(4):329-33. PubMed ID: 1424654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
    Qu L; Li L; Xie H
    Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium activity in the aqueous humor and corneal stroma of the rabbit.
    Stiemke MM; Roman RJ; Palmer ML; Edelhauser HF
    Exp Eye Res; 1992 Sep; 55(3):425-33. PubMed ID: 1330666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.